- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -This follows another recent authorization by Anthem Multiplan for PoNS Device at out-of-network negotiated price of $19,160-

BEDFORD, Mass., June 16, 2025 ( GLOBE NEWSWIRE ) -- Ocular Therapeutix, Inc. ( NASDAQ: OCUL, "Ocular" ) , a fully-integrated biopharmaceutical company committed to redefining the retina experience, today announced participation at Clinical Trials at the Summit 2025, taking place on June 21, ...

Ampere Metals to acquire Virginia Project for a total consideration of US$ 8.0 million: US$5 million for the sale of the mineral rights and US$3 million for the sale of the landholdings over 5 years of scheduled payments

CHICAGO, June 16, 2025 ( GLOBE NEWSWIRE ) -- Chicago Atlantic Real Estate Finance, Inc. REFI, a commercial mortgage real estate investment trust, announced that its board of directors has declared a regular quarterly cash dividend of $0.47 per share for the second quarter of 2025.

Irvine, California, June 16, 2025 ( GLOBE NEWSWIRE ) -- Origence, a leader in credit union lending technology, announced the integration of Experian's PowerCurve® decisioning suite into the Origence arc OS loan and account origination platform.

USAR to Qualify its Magnets for use in Moog's CoreMotion™ Liquid Coolant Distribution Pumps USAR to Qualify its Magnets for use in Moog's CoreMotion™ Liquid Coolant Distribution Pumps ...

PARIS, June 16, 2025 /PRNewswire/ -- Pratt & Whitney, an RTX RTX business, has secured a contract from Dynetics, a Leidos company, to supply TJ150 engines to be integrated with their Small Cruise Missile, known as Black Arrow. The TJ150 is a compact, high performance turbojet engine that can be ...

WATERTOWN, Mass., June 16, 2025 ( GLOBE NEWSWIRE ) -- EyePoint Pharmaceuticals, Inc. ( Nasdaq: EYPT ) , a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory ...

Advancing Lead Program, CR-001, a PD-1 x VEGF Bispecific Antibody, and Developing Pipeline of Novel ADCs as Single Agents and in Combination with CR-001 On Track to Submit IND Application for CR-001 in Fourth Quarter of 2025 with Proof-of-Concept Clinical Data Expected in Second Half of 2026

TORONTO, June 16, 2025 ( GLOBE NEWSWIRE ) -- Fury Gold Mines Limited ( TSX and NYSE American: FURY ) ( "Fury" or the "Company" ) is pleased to announce that is has finalized a number of drill targets at the Sakami gold project located in the Eeyou Istchee Territory in the James Bay region of ...